Jennifer T Loud

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
  2. pmc Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families
    Susan T Vadaparampil
    Division of Population Sciences, Moffitt Cancer Center, Tampa, Flordia, USA
    Hered Cancer Clin Pract 7:11. 2009
  3. ncbi request reprint Applications of advances in molecular biology and genomics to clinical cancer care
    Jennifer T Loud
    Clinical Genetics Branch CGB, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA
    Cancer Nurs 25:110-22; quiz 123-4. 2002
  4. pmc Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer
    Jennifer T Loud
    Clinical Genetics Branch, National Cancer Institute, NIH, Rockville, MD, USA
    BMC Womens Health 9:20. 2009
  5. pmc Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?
    Jennifer T Loud
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 18:1243-51. 2009
  6. ncbi request reprint Deliberate deceit of family members: a challenge to providers of clinical genetics services
    Jennifer T Loud
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services Food and Drug Administration, Rockville, MD 20853 7231, USA
    J Clin Oncol 24:1643-6. 2006
  7. pmc Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families
    June A Peters
    Clinical Genetics Branch CGB, Division of Cancer Epidemiology and Genetics DCEG, National Cancer Institute NCI, National Institutes of Health NIH, Department of Health and Human Services DHHS, Rockville, MD 20852, USA
    J Genet Couns 20:450-64. 2011
  8. pmc BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience
    Alexis D Bakos
    Department of Health and Human Services, National Institute of Nursing Research, NIH, Rockville, MD, USA
    Health Expect 11:220-31. 2008
  9. pmc Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions
    Laura M Koehly
    Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Building 31, Room B1B37D, 31 Center Drive MSC 2073, Bethesda, MD 20892, USA
    Am J Public Health 99:2203-9. 2009
  10. pmc Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer
    Gretchen L Gierach
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Breast Cancer Res Treat 123:245-55. 2010

Collaborators

Detail Information

Publications14

  1. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
    ..2)...
  2. pmc Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families
    Susan T Vadaparampil
    Division of Population Sciences, Moffitt Cancer Center, Tampa, Flordia, USA
    Hered Cancer Clin Pract 7:11. 2009
    ..Our data provide a basis for further exploring psychosocial issues that are specific to men with a family history of TC, and formulating intervention strategies aimed at improving adherence to TSE guidelines...
  3. ncbi request reprint Applications of advances in molecular biology and genomics to clinical cancer care
    Jennifer T Loud
    Clinical Genetics Branch CGB, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA
    Cancer Nurs 25:110-22; quiz 123-4. 2002
    ..We use specific examples to demonstrate the use of genetic information to achieve these objectives and to illustrate principles and strategies that may be applied to a variety of cancers...
  4. pmc Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer
    Jennifer T Loud
    Clinical Genetics Branch, National Cancer Institute, NIH, Rockville, MD, USA
    BMC Womens Health 9:20. 2009
    ..We report DL tolerability in BRCA1/2 mutation-positive and -negative women from an IRB-approved research study...
  5. pmc Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?
    Jennifer T Loud
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 18:1243-51. 2009
    ..Little is known about patient characteristics associated with obtaining nipple aspirate fluid (NAF) and adequate cell counts (> or =10 cells) in ductal lavage specimens from BRCA mutation carriers...
  6. ncbi request reprint Deliberate deceit of family members: a challenge to providers of clinical genetics services
    Jennifer T Loud
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services Food and Drug Administration, Rockville, MD 20853 7231, USA
    J Clin Oncol 24:1643-6. 2006
  7. pmc Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families
    June A Peters
    Clinical Genetics Branch CGB, Division of Cancer Epidemiology and Genetics DCEG, National Cancer Institute NCI, National Institutes of Health NIH, Department of Health and Human Services DHHS, Rockville, MD 20852, USA
    J Genet Couns 20:450-64. 2011
    ..Blocking often seemed to involve bi-directional feedback loops, in keeping with Lepore's Social Constraints and Modulation Theory. Privacy and protectiveness predominated as explanations for long-term blocking...
  8. pmc BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience
    Alexis D Bakos
    Department of Health and Human Services, National Institute of Nursing Research, NIH, Rockville, MD, USA
    Health Expect 11:220-31. 2008
    ..This study was designed to explore cancer risk perception and the experience of being a mutation-negative woman within a known BRCA1/2 mutation-positive family...
  9. pmc Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions
    Laura M Koehly
    Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Building 31, Room B1B37D, 31 Center Drive MSC 2073, Bethesda, MD 20892, USA
    Am J Public Health 99:2203-9. 2009
    ..Given the importance of the dissemination of accurate family history to assess disease risk, we characterized the gatherers, disseminators, and blockers of health information within families at high genetic risk of cancer...
  10. pmc Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer
    Gretchen L Gierach
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Breast Cancer Res Treat 123:245-55. 2010
    ..Taking these factors into account did not significantly alter the results of the age/body mass index-adjusted analysis. Our results do not provide support for an independent effect of BRCA1/2 mutation status on mammographic density...
  11. pmc Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study
    Blanche P Alter
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852 7231, USA
    Br J Haematol 150:179-88. 2010
    ..The findings demonstrate that both FA and DC are major cancer susceptibility syndromes. The IBMFS, historically considered paediatric disorders, have important management implications for physicians treating adult patients...
  12. pmc Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer
    Christine M Mueller
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    BMC Complement Altern Med 8:17. 2008
    ..Complementary and alternative medicine (CAM) use is well documented among breast cancer patients and survivors, but little evidence is available to describe rates and patterns of use among women at increased genetic risk of breast cancer...
  13. pmc Testicular cancer and genetics knowledge among familial testicular cancer family members
    June A Peters
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd, EPS 7026, Rockville, MD 20852, USA
    J Genet Couns 17:351-64. 2008
    ..It was our aim to determine baseline levels of testicular cancer and genetics knowledge among members of families with Familial Testicular Cancer (FTC)...
  14. pmc Meta-analysis identifies four new loci associated with testicular germ cell tumor
    Charles C Chung
    Division of Cancer Epidemiology and Genetics, National Cancer Institute NCI, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA
    Nat Genet 45:680-5. 2013
    ..These new TGCT susceptibility loci contain biologically plausible genes encoding proteins important for male germ cell development, chromosomal segregation and the DNA damage response...